Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognosis

  • Open Access
    Macrophage-related Genomic Signatures Predict HCC Prognosis and Therapy Response
    WENTAO ZHONG, LINQIANG DUAN, FENG ZHANG, CHANGGUI ZOU, JUNYI QIU, SHIXIONG HU, MIN YU and ZI YIN
    Cancer Genomics & Proteomics May 2026, 23 (3) 503-529; DOI: https://doi.org/10.21873/cgp.20587
  • Open Access
    Low CTDNEP1 Expression Predicts Poor Prognosis and Is Associated With Immune Modulation in Pancreatic Cancer
    MAYUKA NII and TADAYOSHI HAYATA
    Cancer Genomics & Proteomics January 2026, 23 (1) 144-154; DOI: https://doi.org/10.21873/cgp.20567
  • Open Access
    Oxysterol-binding Protein-like 3 Promotes Tumor Progression by Regulating Apoptosis and Angiogenesis in Colorectal Cancer
    CHAN-MUK IM, HYUNG-HOON OH, SUN-YOUNG PARK, YOUNG-LAN PARK, JAE-SUNG KIM and YOUNG-EUN JOO
    Cancer Genomics & Proteomics November 2025, 22 (6) 1025-1043; DOI: https://doi.org/10.21873/cgp.20553
  • Open Access
    Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis
    ZHI LI, LI JIA, HUANG-REN ZHOU, LU ZHANG, MENG ZHANG, JUAN LV, ZHI-YONG DENG and CHAO LIU
    Cancer Genomics & Proteomics January 2024, 21 (1) 102-117; DOI: https://doi.org/10.21873/cgp.20433
  • Open Access
    Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance
    AMBER XINYU LI, JIMMY JIANYUAN ZENG, ELYAS KHAN, Q. PING DOU, XINGUO ZHUANG, EDISON KE JI, FIONA RUGE, TRACEY A. MARTIN, SHUQIN JIA and WEN G. JIANG
    Cancer Genomics & Proteomics January 2024, 21 (1) 30-40; DOI: https://doi.org/10.21873/cgp.20427
  • Open Access
    Identification of TTC21A as a Potential Prognostic Marker in Head and Neck Squamous Cell Carcinoma: In Silico Analysis
    LILI WANG, YANPING YIN, PENG LIU, HANXIANG CHEN and MIAO XU
    Cancer Genomics & Proteomics January 2024, 21 (1) 41-53; DOI: https://doi.org/10.21873/cgp.20428
  • Open Access
    CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis
    CHI-FEN CHANG, SHU-PIN HUANG, YU-MEI HSUEH, PEI-LING CHEN, CHENG-HSUEH LEE, JIUN-HUNG GENG, CHAO-YUAN HUANG and BO-YING BAO
    Cancer Genomics & Proteomics September 2023, 20 (5) 469-475; DOI: https://doi.org/10.21873/cgp.20398
  • Open Access
    Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma
    VLASTIMIL KULDA, JIRI POLIVKA, MARTIN SVATON, TOMAS VANECEK, MARCELA BURESOVA, KATERINA HOUFKOVA, MAHYAR SHARIF BAGHERI, TEREZA KNIZKOVA, BOHUSLAVA VANKOVA, JINDRA WINDRICHOVA, PETR MACAN, VACLAV BABUSKA and MARTIN PESTA
    Cancer Genomics & Proteomics July 2023, 20 (4) 404-411; DOI: https://doi.org/10.21873/cgp.20392
  • Open Access
    Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
    YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA
    Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
  • Open Access
    Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
    AKINORI MINATO, YUZAN KUDO, HIROTSUGU NOGUCHI, SHIRO KOHI, YOSHITAKA HASEGAWA, NORIHIRO SATO, KEIJI HIRATA and NAOHIRO FUJIMOTO
    Cancer Genomics & Proteomics March 2023, 20 (2) 203-210; DOI: https://doi.org/10.21873/cgp.20375

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 490
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire